US7722665-B2  D. Kirsch, M.D., et al., "In Vitro Evaluation of Side-Branch Creation in Metal Stents by Balloon Dilatation," The Journal of Applied Research, vol. 3, No. 4, pp. 380-387, 2003.;  G. Kalmar, M.D., et al., "Radial Force and Wall Apposition of Balloon-expandable Vasuclar Stents in Eccentric Stenoses: An In Vitro Evaluation in a Curved Vessel Model," http://www.jvir.org/cgi/content/full/13/5/499, Journal of Vascular and Interventional Radiology, vol. 13, pp. 499-508, (c) 2002 The Society of Cardiovascular&Interventional Radiology, 2002.;  W. Schmidt, et al., "Comparison of mechanical properties of peripheral self-expanding Nitinol and balloon-expandable stainless-steel stents," Electronic Poster, Annual Meeting and Postgraduate Course, Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Barcelona, Spain, 7 pgs, Sep. 2004.;  V. Hoang, "Stent Design and Engineer Coating Over Flow Removal Tool_Team #3 (Vimage)," 9 pgs, Oct. 29, 2004.;  Angiotech Pharmaceuticals, Inc., "Angiotech completes acquisition of Lifespan(R) vascular graft product line from Edwards Lifesciences," http://biz.yahoo.com/prnews/, 2 pgs, Dec. 1, 2005.;  Ho-Wook Jun, et al., "Nitric Oxide-Producting Polyurethanes," (c) 2005 American Chemical Society, Biomacromolecules, vol. 6, No. 2, pp. 838-844, 2005.;  Boston Scientific, "PTCA with Stent," http://www.bostonscientific.com, 9 pgs, (c) 2006.;  J.I. Rotmans, et al., "Hemodialysis access graft failure: Time to revisit an unmet clinical need?" Journal of Nephrology; vol. 18, No. 1, 14 pgs, 2005.;  H. King, M.D., DSC, et al., "Global Burden of Diabetes, 1995-2025: Prevalence, numerical estimates, and projections," Diabetes Care, vol. 21, No. 9, pp. 1414-1431, Sep. 1998.;  H.I. Feldman, et al., "Hemodialysis Vascular Access Morbidity," Journal of the American Society of Nephrology, vol. 7, No. 4, pp. 523-535, 1996.;  R.Y. Kanterman, M.D., et al., "Dialysis Access Grafts: Anatomic Location of Venous Stenosis and Results of Angioplasty," Intervention Radiology, vol. 195, No. 1, pp. 135-139, Apr. 1995.;  M. Rekhter, et al., "Cell proliferation in human arteriovenous fistulas used in hemodialysis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 13, No. 4, cover pg. and pp. 609-617, 1993.;  P. Roy-Chaudhury, et al., "Venouse neointimal hyperplasia in polytertrafluoroethylene dialysis grafts," www.pubmed.gov (abstract only), Kidney Int., 59(6):2325-34, Jun. 2001.;  S.H. Swedberg, et al., "Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment," Circulation, vol. 80, No. 6, cover pg. and pp. 1726-1736, Dec. 1989.;  M.F. Weiss, et al., "Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access," www.pubmed.gov (abstract only), Am J Kidney Dis., 37(5):970-80, May 2001.;  A. Leuprecht, et al., "Numerical study of hemodynamics and wall mechanics in distal end-to-side anastomoses of bypass grafts," Journal of Biomechanics, vol. 35, pp. 225-236, 2002.;  W.M. Abbott, et al., "Effect of compliance mismatch on vascular graft patency," www.pubmed.gov (abstract only), J Vasc Surg., 5(2):376-82, Feb. 1987.;  W. Trubel, et al., "Compliance mismatch and formation of distal anastomotic intimal hyperplasia in externally stiffened and lumen-adapted venous grafts," www.pubmed.gov (abstract only), Eur J Vasc Endovasc Surg., 10(4):415-23, Nov. 1995.;  J.J. Castellot, Jr., et al., "Cultured Endothelial Cells Produce a Heparinlike Inhibitor of Smooth Muscle Cell Growth," Journal of Cell Biolgy, vol. 90, pp. 372-379, Aug. 1981.;  P.L. McNeil, et al., "Growth Factors are Released by Mechanically Wounded Endothelial Cells," Journal of Cell Biology, vol. 109, pp. 811-822, Aug. 1989.;  J.E. O'Brien, Jr., et al., "Early Injury to the Media after Saphenous Vein Grafting," The Annals of Thoracic Surgery, vol. 65, Issue 5, http://www.sciencedirect.com (abstract only), pp. 1273-1278, May 1998.;  G. Pertosa, et al., "Clinical relevance of cytokine production in hemodialysis," www.pubmed.gov (abstract only), Kidney Int Suppl., 76: S104-11, Aug. 2000.;  G.R. Grotendorst, et al., "Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells," www.pubmed.gov (abstract only), J Cell Physiol. 113(2):261-6, Nov. 1982.;  A.C. Newby, et al., "Molecular mechanisms in intimal hyperplasia," www.pubmed.gov (abstract only), J Pathol. 190(3):300-9, Feb. 2000.;  V. Lindner, et al., "Role of basic fibroblast growth factor in vascular lesion formation," Circ. Res., vol. 68, No. 1, cover page and pp. 106-113, Jan. 1991.;  A. Jawien, et al., "Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty," www.pubmed.gov (abstract only), J Clin Invest., 89(2):507-11, Feb. 1992.;  M.J. Daemen, et al., "Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall," Circ. Res. vol. 68, No. 2, cover page and pp. 450-456, Feb. 1991.;  H. Rakugi, et al., "Vascular injury induces angiotensinogen gene expression in the media and neointima," Circulation, vol. 87, No. 1, cover page and pp. 283-290, Jan. 1993.;  J.I. Rotmans, et al., "Rapid, arteriovenous graft failure due to intimal hyperplasia: a porcine, bilateral, carotid arteriovenous graft model," www.pubmed.gov (abstract only), J Surg Res. 113(1):161-171, Jul. 2003.;  R. Dammers, et al., "Evaluation of 4-mm to 7-mm versus 6-mm prosthetic brachial-antecubital forearm loop access for hemodialysis: results of a randomized multicenter clinical trial," www.pubmed.gov (abstract only), J Vasc Surg. 37(1):143-8, Jan. 2003.;  D. Mehta, et al., "External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting," www.pubmed.gov (abstract only), Nat Med., 4(2):235-9, Feb. 1998.;  P.J. Gagne, et al., "The effect of venous anastomosis Tyrell vein collar on the primary patency of arteriovenous grafts in patients undergoing hemodialysis," www.pubmed.gov (abstract only), J Vasc Surg. 32(6):1149-54, Dec. 2000.;  J. E. Rosenman, et al., "Kinetics of endothelial cell seeding," www.pubmed.gov (abstract only), J Vasc Surg. 2(6):778-84, Nov. 1985.;  M. Deutsch, et al., "Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience," www.pubmed.gov (abstract only), Surgery, 126(5):847-55, Nov. 1999.;  R. Saran, et al., "Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS)," www.pubmed.gov (abstract only), Am J Kidney Dis. 40(6):1255-63, Dec. 2002.;  J.S. Kaufman, et al., "Randomized Controlled Trial of Clopidogrel plus Aspirin to Prevent Hemodialysis Access Graft Thrombosis," J Am Soc Nephrol. vol. 14, pp. 2313-2321, 2003.;  V.M. Rodriguez, M.D., et al., "Effects of Brachytherapy on Intimal Hyperplasia in Arteriovenous Fistulas in a Porcine Model," J Vase Interv Radiol., vol. 13, No. 12, pp. 1239-1246, Dec. 2002.;  S. Sun, et al., "Inhibitory effect of brachytherapy on intimal hyperplasia in arteriovenous fistula," www.pubmed.gov (abstract only), J Surg Res. 115(2):200-8, Dec. 2003.;  J. Barton, et al., "PhotoPoint photodynamic therapy inhibits intimal hyperplasia in arteriovenous access grafts," www.pubmed.gov (abstract only), Cardiovasc Radiat Med., 3(3-4):147-51, Jul.-Dec. 2002.;  J.I. Rotmans, M.D., et al., "Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model," http://www.sciencedirect.com (abstract only), J Vasc Surg., vol. 39, Issue 2, pp. 432-439, Feb. 2004.;  M.P. Bendeck, et al., "Doxycycline Modulates Smooth Muscle Cell Growth, Migration, and Matrix Remodeling after Arterial Injury," American Journal of Pathology, vol. 160, No. 3, pp. 1089-1095, Mar. 2002.;  M.J. Englesbe, et al ., "Concomitant blockade of paletelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts," www.pubmed.gov (abstract only), J Vasc Surg. 39(2):446-6, Feb. 2004.;  M.R. Kibbe, et al., "Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia," www.pubmed.gov (abstract only), J Vasc Surg., 34(1):156-65, Jul. 2001.;  Hyun-Jai Cho, et al., "Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation," Circulation, 108:2918-25, Oct. 20, 2003.;  J. Llevadot, et al., "HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells," Journal of Clinical Investigation, vol. 108, No. 3, pp. 399-405, Aug. 2001.;  D.H. Walter, et al., "Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells," Circulation, vol. 105, cover page, and pp. 3017-3024, May 20, 2002.;  V. Bhattacharya, et al., "Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells," Hemostasis, Thrombosis, and Vascular Biology, vol. 95, No. 2, pp. 581-585, Jan. 15, 2000.;  G.A. Beathard, "Percutaneous transvenous angioplasty in the treatment of vascular access stenosis," www.pubmed.gov (abstract only), Kidney Int. 42(6):1390-7, Dec. 1992.;  D. Vorwerk, M.D., et al., "Venous Stenosis and Occlusion in Hemodialysis Shunts: Follow-up Results of Stent Placement in 65 patients," Radiology, vol. 195, No. 1, pp. 140-146, Apr. 1995.;  J.I. Rotmans, et al., "Sirolimus-Eluting Stents to Abolish Intimal Hyperplasia and Improve Flow in Porcine Arteriovenous Grafts: A 4-Week Follow-up Study," Circulation, vol. 111, cover page and pp. 1537-1542, Mar. 29, 2005.;  M.C. Morice, et al., "A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization," www.pubmed.gov (abstract only), N Eng J Med., 346(23):1773-80, Jun. 6, 2002.;  A. Colombo, et al., "Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions," Circulation, vol. 108, cover page and pp. 788-794, Aug. 4, 2003.